In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Mindray Medical International nets $133.6mm in US IPO

Executive Summary

Chinese medical device company Mindray Medical International (also known as Shenzhen Mindray Bio-Medical) completed its initial public offering on the New York Stock Exchange netting $133.6mm The company issued 10.6mm American Depository Shares at $13.50 each (above the $10-12 it had expected to get); selling shareholders issued an additional 9.4mm ADSs.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies